This NDC is on FDA's drug shortage list (posted Jul 26, 2023)
Product Information
METHYLPHENIDATE ER 18 MG TAB is a generic product labeled by Actavis Pharma, Inc., priced at $0.5758 per EA under NDC 62037072501. Its NADAC has been published 382 times since May 1, 2019.
FDA first approved this application on Mar 22, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
18 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
62037072501
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076772FDA Approved
3/22/2018
TE Code
AB
On Market Since
3/4/2019
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE ER 18 MG TAB has been published 382 times since May 1, 2019, and over the history we have for it it has declined 90.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5758 per EA |
|---|---|
| All-time high | $6.1790 (May 15, 2019) |
| All-time low | $0.5230 (Jul 20, 2022) |
| 52-week high | $0.7051 |
| 52-week low | $0.5758 |
| Median price | $0.7306 |
| Average price | $1.4300 |
| Largest weekly change | -50.2% (Jul 22, 2020) |
| Weeks tracked | 382 |
| Tracking since | May 1, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE ER 18 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 18 MG TAB, manufactured by Actavis Pharma, Inc., is $0.5758 per EA (NDC 62037072501), effective Aug 19, 2026.
How has the price of METHYLPHENIDATE ER 18 MG TAB changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE ER 18 MG TAB has declined 90.7%. It has been tracked across 382 weekly CMS publications since May 1, 2019.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 18 MG TAB?
Since May 1, 2019, the NADAC for METHYLPHENIDATE ER 18 MG TAB has ranged from a low of $0.5230 (Jul 20, 2022) to a high of $6.1790 (May 15, 2019), with a median of $0.7306 per EA.
Are there cheaper alternatives to METHYLPHENIDATE ER 18 MG TAB?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPHENIDATE ER 18 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLPHENIDATE ER 18 MG TAB?
METHYLPHENIDATE ER 18 MG TAB (NDC 62037072501) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.
Is METHYLPHENIDATE ER 18 MG TAB in shortage?
Yes — NDC 62037072501 is currently listed in FDA's drug shortage database (posted Jul 26, 2023).